Federal opportunity · Award Notice
AwardedBupropion HCL ER
SPE2D2-23-D-0002 · Dept of Defense · SAM.gov
Awarded to RADHA PHARMACEUTICALS INC Hauppauge NY 11788 USA · $23,278,524 · Oct 6, 2022
Who won it
- Awardee
- RADHA PHARMACEUTICALS INC Hauppauge NY 11788 USA
- Amount
- $23,278,524
- Award date
- Oct 6, 2022
- Posted
- Sep 14, 2026
- NAICS code
- 325412 · Pharmaceutical Preparation Manufacturing
- Set-aside
- None
- Place of performance
- Hauppauge, Ny
- Notice type
- Award Notice
- Solicitation number
- SPE2D2-23-D-0002
- Official notice
- View on SAM.gov →
Open opportunities in Pharmaceutical Preparation Manufacturing
- Methylphenidate ERDept of Defense · Due Nov 6, 2026 · Under a day left
- Medical Gas Cylinders, USP, Type I-DOT 3AA SteelDept of Defense · Due Nov 15, 2026 · 9 days left
- Epinephrine InjectorDept of Defense · Due Nov 16, 2026 · 10 days left
- Atropine Auto-InjectorDept of Defense · Due Nov 30, 2026 · 24 days left
- FentanylDept of Defense · No deadline listed
- Morphine Sulfate SolutionDept of Defense · No deadline listed
What the agency bought
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.
Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER
From the official notice on SAM.gov.